D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Tesla
TSLA
|
+$765M |
| 2 |
Baidu
BIDU
|
+$627M |
| 3 |
Coca-Cola
KO
|
+$444M |
| 4 |
NVIDIA
NVDA
|
+$380M |
| 5 |
Tencent Music
TME
|
+$344M |
Top Sells
| 1 |
Amazon
AMZN
|
+$957M |
| 2 |
Wells Fargo
WFC
|
+$743M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$604M |
| 4 |
GameStop
GME
|
+$532M |
| 5 |
DuPont de Nemours
DD
|
+$420M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Consumer Discretionary | 13.32% |
| 3 | Healthcare | 10.88% |
| 4 | Communication Services | 10.66% |
| 5 | Financials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Repligen
RGEN
$6.72B
| $1.08M | ﹤0.01% |
5,576
-35,998
| -87% | -$7M |
|
|
DHHCU
2002
DELISTED
DiamondHead Holdings Corp. Unit
DHHCU
| $1.08M | ﹤0.01% |
+109,369
| New | +$1.08M |
|
2003
Atlanta Braves Holdings Series A
BATRA
$2.84B
| $1.08M | ﹤0.01% |
37,935
-4,821
| -11% | -$138K |
|
2004
Pulmonx
LUNG
$65.6M
| $1.08M | ﹤0.01% |
+23,636
| New | +$1.08M |
|
2005
Kimball Electronics
KE
$735M
| $1.08M | ﹤0.01% |
41,841
-8,339
| -17% | -$215K |
|
2006
Ascendis Pharma
ASND
$12B
| $1.08M | ﹤0.01% |
8,367
-14,241
| -63% | -$1.83M |
|
2007
Insteel Industries
IIIN
$745M
| $1.07M | ﹤0.01% |
34,800
-17,748
| -34% | -$547K |
|
2008
Seres Therapeutics
MCRB
$154M
| $1.07M | ﹤0.01% |
2,606
-17,144
| -87% | -$7.06M |
|
|
USX
2009
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $1.07M | ﹤0.01% |
91,048
-123,978
| -58% | -$1.46M |
|
2010
Corbus Pharmaceuticals
CRBP
$118M
| $1.07M | ﹤0.01% |
18,043
-51,095
| -74% | -$3.02M |
|
2011
SK Telecom
SKM
$8.33B
| $1.07M | ﹤0.01% |
23,782
+10,725
| +82% | +$481K |
|
2012
Fidus Investment
FDUS
$754M
| $1.07M | ﹤0.01% |
68,540
+45,727
| +200% | +$711K |
|
|
FPI
2013
Farmland Partners
FPI
$471M
| $1.06M | ﹤0.01% |
94,899
-114,890
| -55% | -$1.29M |
|
2014
Shinhan Financial Group
SHG
$23.7B
| $1.06M | ﹤0.01% |
31,649
+14,945
| +89% | +$501K |
|
|
LOKM.U
2015
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
| $1.06M | ﹤0.01% |
+106,400
| New | +$1.06M |
|
2016
Clean Energy Fuels
CLNE
$561M
| $1.06M | ﹤0.01% |
77,192
+7,388
| +11% | +$102K |
|
2017
Park Hotels & Resorts
PK
$2.36B
| $1.06M | ﹤0.01% |
+49,062
| New | +$1.06M |
|
2018
Northwest Bancshares
NWBI
$1.83B
| $1.06M | ﹤0.01% |
73,215
+46,166
| +171% | +$667K |
|
2019
Metropolitan Bank Holding Corp
MCB
$813M
| $1.06M | ﹤0.01% |
20,965
+10,525
| +101% | +$530K |
|
2020
The Greenbrier Companies
GBX
$1.42B
| $1.05M | ﹤0.01% |
+22,311
| New | +$1.05M |
|
2021
Diamondback Energy
FANG
$40.4B
| $1.05M | ﹤0.01% |
14,278
-570,608
| -98% | -$41.9M |
|
2022
Papa John's
PZZA
$1.63B
| $1.05M | ﹤0.01% |
11,813
+9,276
| +366% | +$822K |
|
2023
Emerald Holding
EEX
$960M
| $1.04M | ﹤0.01% |
189,180
-90,238
| -32% | -$498K |
|
|
HZON
2024
DELISTED
Horizon Acquisition Corporation II
HZON
| $1.04M | ﹤0.01% |
+102,386
| New | +$1.04M |
|
2025
BioNTech
BNTX
$25.1B
| $1.03M | ﹤0.01% |
9,459
-46,439
| -83% | -$5.07M |
|